CCHIO, a Milestone Event for the Global Cancer Community, Returns to Tianjin in 2023
Bringing together expertise to pool wisdom in China and around the world.
环球评报新闻网中国天津讯 | The 2023 edition of the Chinese Congress of Holistic Integrative Oncology has been held from November 16th to 19th in Tianjin, China. Organized by the China Anti-Cancer Association and co-hosted by Tianjin Medical University Cancer Institute & Hospital, Tianjin Anti-Cancer Association, and the China Institute of Integrative Medicine Development Strategy, the congress aims to strengthen the action and impact of the cancer community. It has been featured over one hundred sessions covering the full spectrum of cancer, from prevention to palliative care, with the attendance of many academicians and top-level experts.
The Chinese Congress on Oncology (CCO), established by the China Anti-Cancer Association (CACA) in 2000, has a history of more than twenty years and is a highly influential academic conference in the field of oncology in China. Over the years, the CACA has been adhering to the concept of integrated medicine with the motto ‘Cancer prevention and control win through integration.’ Starting this year, the CCO has been renamed the Chinese Congress of Holistic Integrative Oncology (CCHIO).
The Chinese Congress of Holistic Integrative Oncology (CCHIO) is an internationally recognized academic event that facilitates effective knowledge transfer and best practices exchange among global cancer prevention and health experts. Using a "1 + N" model, there has been a main venue in Tianjin and 30 satellite venues in provinces and cities across the country.
During the congress, prestigious scholars has been discussing global strategies for cancer prevention, treatment, and control. They also presented the latest, cutting-edge scientific and clinical advances across the entire field of oncology of relevance at a global level, and for the Asia-Pacific region. The CCHIO serves as a base, platform, and lever to actively consolidate expert knowledge, academic accomplishments, advanced technologies, and industry resources to advance the development of an integrated oncology medical service system. It supports a mission statement "Bringing about expertise to pool wisdom in China and around the world".